KINTOR PHARMA-B(09939) proposed appointing RSM Hong Kong as the new auditor.

date
22:27 26/05/2026
avatar
GMT Eight
Kaituo Pharmaceutical-B (09939) announced that, considering that PricewaterhouseCoopers has been serving for many years, in order to maintain good corporate governance and ensure the independence and objectivity of auditing work, it is now an appropriate time to rotate the auditor. Therefore, after the expiration of the current term, PricewaterhouseCoopers will retire as the company's auditor at the end of the annual general meeting of shareholders to be held on June 18, 2026.
KINTOR PHARMA-B (09939) announced that in consideration of the long tenure of PwC and to maintain good corporate governance and ensure the independence and objectivity of the audit work, it is now an appropriate time to rotate the auditors. Therefore, PwC will retire as the company's auditor after the end of its current term, which will be at the annual general meeting of shareholders scheduled for June 18, 2026. After considering the recommendation of the audit committee, the board has decided to propose the appointment of Ernst & Young (Hong Kong) as the company's new auditor after PwC retires, to be effective after the annual general meeting of shareholders on June 18, 2026. However, this appointment is subject to approval by the shareholders at the annual general meeting.